Trailing-twelve-month (TTM) revenue is $713.54 Million with a year-over-year growth of +32.21%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $200,138,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $157,544,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $188,112,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $167,744,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $713,538,000 |
Current P/S: $2,200,572,225 market capitalization ÷ $713,538,000 TTM revenue = 3.08x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:20:15.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $167.74M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:21:49.091Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Platform And Usage Based Fees | $53M | $65M | $73M | N/A | N/A |
| Transactions | $148M | $224M | $330M | $410M | $503M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Asia and Pacific (APAC) | N/A | $26M | $60M | $82M | $96M |
| CANADA | $28M | N/A | N/A | N/A | N/A |
$713.54M
$713.54 Million
+32.21%
vs. $539.70M a year ago (TTM)
+35.32%
5 Year compound annual growth rate
1 Year
+32.21%
3 Year
+27.09%
5 Year
+35.32%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $623.02M | +$130.88M | +26.59% |
| 2024 | $492.14M | +$89.05M | +22.09% |
| 2023 | $403.09M | +$113.72M | +39.30% |
| 2022 | $289.38M | +$88.23M | +43.86% |
| 2021 | $201.15M | +$69.37M | +52.64% |
| 2020 |
TTM Growth
+32.21%
3-Year CAGR
+27.09%
5-Year CAGR
+35.32%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:21:49.091Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Europe, the Middle East and Africa (EMEA) |
|---|
| N/A |
| $69M |
| $121M |
| $189M |
| $241M |
| Other Countries | $14M | N/A | N/A | N/A | N/A |
|---|
| UNITED KINGDOM | $28M | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $132M | N/A | N/A | N/A | N/A |
|---|
| United States and Canada (Americas) | N/A | $194M | $223M | $222M | $286M |
|---|
| $131.78M |
| +$36.87M |
| +38.84% |
